Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy

Journal of Hypertension

Volumn 25, Issue 9, 2007, Pages 1940-1950

  Cavallero, Susana ^a,c   González, Germán E ^b   Puyó, Ana M ^a   Rosón, María I ^a   Pérez, Susana ^a   Morales, Celina ^a   Hertig, Cecilia M ^c   Gelpi, Ricardo J ^a   Fernández, Belisario E ^a  

^a Laboratory of Free Radical Biology   (Argentina)

^b Lab Exp Hypertension Vasoactive S   (Argentina)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Atrial natriuretic peptide; Cardiac hypertrophy; DOCA salt hypertension; Natriuretic peptides; Renovascular hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DEOXYCORTICOSTERONE ACETATE; MESSENGER RNA; NATRIURETIC PEPTIDE TYPE C; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; HEART VENTRICLE VOLUME; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; RENOVASCULAR HYPERTENSION;

EID: 34548419720     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e3282435b1e     Document Type: Article

References (31)

1. Opie LH, Commerford PJ, Gersh BJ, Pfeffer MA. Controversies in ventricular remodelling. Lancet 2006; 367:356-367.
2. Muiesan ML, Salvetti M, Monteduro C, Bonzi B, Paini A, Viola S, et al. Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients. Hypertension 2004; 43:731-738.
3. Devereux RB, Roman MJ, Ganau A, de Simone G, Okin PM, Kligfield P. Cardiac and arterial hypertrophy and atherosclerosis in hypertension. Hypertension 1994; 23:802-809.
4. Kvist S, Mulvany MJ. Contrasting regression of blood pressure and cardiovascular structure in declipped renovascular hypertensive rats. Hypertension 2003; 41:540-545.
5. Morgan T, Aubert JF, Brunner H. Interaction between sodium intake, angiotensin II, and blood pressure as a cause of cardiac hypertrophy. Am J Hypertens 2001; 14:914-920.
6. + channels in the rat. Mol Cell Biochem 2002; 237:1-10.
7. Dobrzynski E, Wang C, Chao J, Chao L. Adrenomedullin gene delivery attenuates hypertension, cardiac remodeling, and renal injury in deoxycorticosterone acetate-salt hypertensive rats. Hypertension 2000; 36:995-1001.
8. De Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996; 31:7-18.
9. Gardner DG. Natriuretic peptides: markers or modulators of cardiac hypertrophy? Trends Endocrinol Metab 2003; 14:411-416.
10. McGrath MF, de Bold ML, de Bold AJ. The endocrine function of the heart. Trends Endocrinol Metab 2005; 16:469-477.
11. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides 2005; 26:901-932.
12. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 1996; 93:2059-2067.
13. Bianciotti LG, de Bold AJ. Modulation of cardiac natriuretic peptide gene expression following endothelin type A receptor blockade in renovascular hypertension. Cardiovasc Res 2001; 49:808-816.
14. Bianciotti LG, de Bold AJ. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor. Am J Physiol Heart Circ Physiol 2002; 282:H1127-1134.
15. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocrine Rev 2003; 24:341-356.
16. González GE, Palleiro J, Monroy S, Pérez S, Rodriguez M, Masucci A, et al. Effects of the early administration of losartan on the functional and morphological aspects of postmyocardial infarction ventricular remodeling in rabbits. Cardiovasc Pathol 2005; 14:88-95.
17. Tamura T, Onodera T, Said S, Gerdes AM. Correlation of myocyte lengthening to chamber dilation in the spontaneously hypertensive heart failure (SHHF) rat. J Mol Cell Cardiol 1998; 30:2175-2181.
18. Sarda IR, de Bold ML, de Bold AJ. Optimization of atrial natriuretic peptide immunoassay. Clin Biochem 1989; 22:11-15.
19. Puyó AM, Scaglione J, Auger S, Cavallero S, Donoso AS, Dupuy HA, Fernández BE. Atrial natriuretic peptide as marker of myocardial compromise in Chagas' disease. Regul Pept 2002; 105:139-143.
20. Su X, Brower G, Janicki JS, Chen YF, Oparil S, Dell'Italia LJ. Differential expression of natriuretic peptides and their receptors in volume overload cardiac hypertrophy in the rat. J Mol Cell Cardiol 1999; 31:1927-1936.
21. Wang D, Oparil S, Feng JA, Li P, Perry G, Chen LB, et al. Effects of pressure overload on extracellular matrix expression in the heart of the atrial natriuretic peptide-null mouse. Hypertension 2003; 42:88-95.
22. Yu H, Rakugi H, Higaki J, Morishita R, Mikami H, Ogihara T. The role of activated vascular angiotensin II generation in vascular hypertrophy in one-kidney, one clip hypertensive rats. J Hypertens 1993; 11:1347-1355.
23. Fenoy FJ, Tornel J, Madrid MI, Lopez E, Garcia-Salom M. Effects of N-nitro-L-arginine and N-acetyl-L-cysteine on the reversal of one-kidney, one-clip hypertension. Am J Hypertens 1997; 10:1208-1215.
24. Ogawa T, Linz W, Scholkens BA, de Bold AJ. Variable renal atrial natriuretic peptide gene expression in hypertension. Hypertension 1999; 33:1342-1347.
25. Tajima Y, Ichikawa S, Sakamaki T, Matsuo H, Aizawa F, Kogure M, et al. Body fluid distribution in the maintenance of DOCA-salt hypertension in rats. Am J Physiol 1983; 244:H695-H700.
26. Fink GD, Johnson RJ, Galligan JJ. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension 2000; 35:464-469.
27. An MR, Chung YJ, Kang DG, Nam SC, Lee J. Augmented expression of cardiac atrial natriuretic peptide system in hypertensive rats. J Korean Med Sci 1999; 14:497-501.
28. Matsukawa N, Grzesik WJ, Takahashi N, Pandey KN, Pang S, Yamauchi M, et al. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system. Proc Natl Acad Sci U S A 1999; 96:7403-7408.
29. Anand-Srivastava MB. Natriuretic peptide receptor-C signaling and regulation. Peptides 2005; 26:1044-1059.
30. Nagase M, Ando K, Katafuchi T, Kato A, Hirose S, Fujita T. Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats. Hypertension 1997; 30:177-183.
31. Liu LM, Yoshimi T. The changes in natriuretic peptide receptors (NP-R) in the lung and kidney in DOCA-salt hypertensive rats. Nippon Naibunpi Gakkai Zasshi 1995; 71:587-596.